Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | LPAR3 | Q9UBY5 | 8/20 | 0.48 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.48 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12746669 | 0.86 | — | — | |
| SCHEMBL575630 | 0.81 | CYP3A4 (0.61) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL17266706 | 0.81 | CYP3A4 (0.50) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL575395 | 0.79 | CYP3A4 (0.58) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL2479030 | 0.79 | CYP3A4 (0.58) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL5488752 | 0.79 | CYP3A4 (0.58) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL7738766 | 0.77 | CYP3A4 (0.56) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| Alcohol SCHEMBL28153664 | 0.76 | CYP3A4 (0.85) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| Alcohol SCHEMBL9132791 | 0.76 | CYP3A4 (0.85) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL5407462 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180142321-A1 | USE OF NOVEL COMPOUNDS FOR SELECTIVELY EXTRACTING RARE EARTHS FROM AQUEOUS SOLUTIONS INCLUDING PHOSPHORIC ACID AND ASSOCIATED EXTRACTION METHOD | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180142321-A1 | USE OF NOVEL COMPOUNDS FOR SELECTIVELY EXTRACTING RARE EARTHS FROM AQUEOUS SOLUTIONS INCLUDING PHOSPHORIC ACID AND ASSOCIATED EXTRACTION METHOD | HRH3, ALK, H1-0 | CYP3A4 2943/4885LPAR3 33/4885LPAR2 118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.